Sleep Physiology and pharmacotherapy Flashcards
Benzos and non-benzo receptor agonists’ mechanism of action
facilitate GABA at GABAa receptor-chloride channel complex –> membrane hyperpolarization
Triazolam pharmacokinetics
1.5-5h half-life, less daytime sedation (hangover). Rapid elimination –> rebound insomnia the next day. rapid absorption
Temazepam pharmacokinetics
9-13h half-life. slow absorption. peak effect at 2-3h
Flurazepam pharmacokinetics
75-90h half-life. little tolerance. Hepatic clearance (can accumulate in elderly –> daytime sedation, hangover, OD)
Zolpidem and zaleplon pharmacokinetics
6-8h duration. rapid oral absorption
Eszopiclone (Lunesta) pharmacokinetics
longer half-life than zolpidem and zapelon
First line in tx of insomnia
Z drugs. Little effect on sleep stages III and IV
Zolpidem role in insomnia tx
reduces sleep latency and nocturnal awakenings –> increased total sleep time and efficiency
Zaleplon role in insomnia tx
decreases time to sleep onset, no effect on awakening or total sleep time. Used for patients who fall asleep without sleep aid, but wake up in middle of night.
Eszopiclone role in insomnia tx
safest for long-term use
Benzo role in insomnia tx
declining use. cheaper than Z drugs. short-term tx of insomnia
trazodone side effects
oversedation and orthostasis (alpha adrenergic block)
TCAD side effects
antimuscarinic and antiadrenergic activity
Ramelteon
melatonin agonist –> induce sleepiness, regulates circadian rhythms
ADRs: dizziness, somnolence, fatigue, nausea
Antihistamines
H1 and muscarinic cholinergic antagonist